Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.
2.

Dysplastic tubular epithelium in "normal" kidney associated with renal cell carcinoma.

Mourad WA, Nestok BR, Saleh GY, Solez K, Power RF, Jewell LD.

Am J Surg Pathol. 1994 Nov;18(11):1117-24.

PMID:
7943532
3.

Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas.

Pepe S, Ruggiero A, D'Acquisto M, De Laurentiis M, De Placido S, Sandomenico C, Staibano S, De Rosa G, Lucariello A, D'Armiento M, Bianco AR.

Cancer. 2000 Sep 1;89(5):1065-75.

PMID:
10964337
4.

Tubular dysplasia and carcinoma in situ: precursors of renal cell carcinoma.

Yörükoğlu K, Aktas S, Mungan MU, Kirkali Z.

Urology. 1999 Apr;53(4):684-9.

PMID:
10197841
5.

p53 and HER-2 alterations in renal cell carcinoma.

Zhang XH, Takenaka I, Sato C, Sakamoto H.

Urology. 1997 Oct;50(4):636-42.

PMID:
9338750
6.

Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.

Zhou M, Yang XJ, Lopez JI, Shah RB, Hes O, Shen SS, Li R, Yang Y, Lin F, Elson P, Sercia L, Magi-Galluzzi C, Tubbs R.

Am J Surg Pathol. 2009 Dec;33(12):1840-9. doi: 10.1097/PAS.0b013e3181be22d1.

PMID:
19898225
7.

p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.

Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C.

Mod Pathol. 2001 May;14(5):397-403.

8.

Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.

Furihata M, Sonobe H, Ohtsuki Y, Yamashita M, Morioka M, Yamamoto A, Terao N, Kuwahara M, Fujisaki N.

J Pathol. 1996 Feb;178(2):133-9.

PMID:
8683378
9.

p53 expression in human renal cell carcinoma: an immunohistochemical study and a literature outline of the cytogenetic characterization.

Tomasino RM, Morello V, Tralongo V, Nagar C, Nuara R, Daniele E, Curti M, Orestano F.

Pathologica. 1994 Jun;86(3):227-33. Review.

PMID:
7808790
11.

Premalignant lesions in the kidney.

Kirkali Z, Yorukoglu K.

ScientificWorldJournal. 2001 Dec 7;1:855-67.

12.

[Expression of S100 protein in renal cell carcinoma and its relation with P53].

Yang JF, Zhang XY, Qi F.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Jun;29(3):301-4. Chinese.

13.
14.

Tissue expression and plasma levels of adrenomedullin in renal cancer patients.

Michelsen J, Thiesson H, Walter S, Ottosen PD, Skøtt O, Jensen BL.

Clin Sci (Lond). 2006 Jul;111(1):61-70.

PMID:
16515534
15.

The relationship of expression of bcl-2, p53, and proliferating cell nuclear antigen (PCNA) to cell proliferation and apoptosis in renal cell carcinoma.

Zhu Z, Xing S, Cheng P, Li G, Yang Y, Zeng F, Lu G.

J Huazhong Univ Sci Technolog Med Sci. 2004;24(4):354-7.

PMID:
15587397
16.

Differential expression of activator protein-2 isoforms in renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Miyajima A, Horiguchi Y, Nakashima J, Marumo K, Mukai M, Murai M.

Urology. 2004 Jul;64(1):162-7.

PMID:
15245963
17.
18.

Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB.

Am J Surg Pathol. 2006 Feb;30(2):141-53.

PMID:
16434887
19.

p53 protein expression in transitional mucosa and adenocarcinomas of the colorectum.

Connelly JH, Bruner JM, Robey-Cafferty SS, Sahin A.

Mod Pathol. 1992 Sep;5(5):537-9.

PMID:
1344817
20.

p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.

Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, van der Waal I.

J Pathol. 1998 Apr;184(4):360-8.

PMID:
9664901

Supplemental Content

Support Center